Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: MMP Revenue Summary - $293.6M Total
Reply New Message
Prev Message Back To Forum Threaded View Next Message

MMP Revenue Summary - $293.6M Total

posted on Jan 12, 2010 12:19PM
Prior to Merger 2006 2007 2008 2009 2010 Totals
Revenues $ 23,050,000 $ 60,000,000 $ 110,878,985 $ 59,282,971 $ 29,392,424 $ 11,023,655 $ 293,628,035
Operating expenses $ - $ 4,486,955 $ 12,189,575 $ 18,627,032 $ 7,793,472 $ 4,035,901 $ 47,132,935
Operating income $ 23,050,000 $ 55,513,045 $ 98,689,410 $ 40,655,939 $ 21,598,952 $ 6,987,754 $ 246,495,100
Interest income $ - $ 183,682 $ 421,407 $ 216,902 $ 58,987 $ 380 $ 881,358
Income before Taxes $ 23,050,000 $ 55,696,727 $ 99,110,817 $ 40,872,841 $ 21,657,939 $ 6,988,134 $ 247,376,458
Provision for Taxes $ - $ - $ 11,790 $ 11,790 $ 11,790 $ - $ 35,370
Net Income $23,050,000 $55,696,727 $99,099,027 $ 40,861,051 $21,646,149 $ 6,988,134 $247,341,088
Moore & TPL's Portion $ 11,525,000 $ 27,848,364 $ 49,549,514 $ 20,430,526 $ 10,823,075 $ 3,494,067 $ 123,670,544
PTSC's Portion $ 11,525,000 $ 27,848,364 $ 49,549,514 $ 20,430,526 $ 10,823,075 $ 3,494,067 $ 123,670,544
2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply